Novel Tx Helps Some Advanced Cervical Cancer Patients

(MedPage Today) -- One-fourth of patients with previously treated, relapsed, or metastatic cervical cancer responded to an investigational antibody-drug conjugate, according to results of a preliminary trial.
Results in 101 patients showed that...